12 February 2010
Spindles give cancer clues
Cancer scientists working at the University of Dundee have discovered a form of stem cell activity that may help lead to early identification of the disease.
Early diagnosis and treatment of many cancers can be key in limiting the effects of the disease. This new research, published in the scientific journal Cell Stem Cell, reveals differences in the way stem cells behave in normal tissue compared with their activity in tissue that is pre-cancerous.
The research team led by Professor Inke Näthke, and funded by Cancer Research UK, examined the behaviour of mitotic spindles - structures that separate genetic material during the key process of cell division.
Using state-of-the-art imaging techniques, they were able to generate three-dimensional pictures of mitotic spindles in intestinal tissue. They found that they behaved differently in tissue with a single mutation associated with bowel (colorectal) cancer than they did in normal, healthy tissue.
Stem cells are crucial for the normal maintenance of many tissues. They are also involved in the re-generation of damaged tissues. Their role in cancer, and also their enormous potential in treating diseases, makes understanding their biology crucial.
'The process we were investigating is called asymmetric cell division,' said Professor Näthke, a Principal Investigator in the Dundee Cancer Centre. 'The importance of asymmetric divisions for stem cell function and maintenance is well established in the developing nervous system and the skin. However, its role in gut tissue and its role in helping to produce tumours are still debated.'
'We developed an imaging technique that permits the visualisation of three-dimensional aspects of tissue architecture to identify differences in stem and non-stem cells in the intestinal tract. Using this technique, we found that this process of asymmetric division in stem cells is lost in tissue that gives rise to cancers in the gut, so these spindles behave differently in pre-cancerous tissue.'
'In the healthy tissue this process works well. In the precancerous tissue it seems to be compromised, which is an important sign, as this tissue otherwise appears normal.'
'This is important as it may have implications in developing techniques for identifying pre-cancerous tissue at an early stage, when it still appears normal, giving clinicians a chance to catch the disease in the early stages of development. It might also have implications for the types of treatment that should be considered.'
The work combined excellence across the College of Life Sciences and the School of Medicine at Dundee, together with other collaborators including researchers at the Beatson Institute for Cancer Research in Glasgow, and the Netherlands.
'This is a perfect example of the kind of cross-disciplinary work we expect to be doing under the auspices of the new Dundee Cancer Centre launched last week with Cancer Research UK,' said Professor Näthke.
'We have combined expertise in imaging, pathology, surgery and cellular science to make these findings.'
The work was funded by the Bobby Moore Fund for Cancer Research UK.
NOTES TO EDITORS
About the University of Dundee:
The University of Dundee has powered its way to an internationally recognised position of excellence in life sciences and medical research with particular expertise in cancer, diabetes, cardiovascular disease and tropical diseases. The University, together with NHS Tayside, has been awarded Cancer Centre status by Cancer Research UK. Dundee’s scientific research is consistently among the top-rated in the UK for impact. See www.dundee.ac.uk for further details.
About The Bobby Moore Fund:
- The Bobby Moore Fund for Cancer Research UK raises vital funds for research into bowel cancer and increases public awareness of the disease
- The Fund was set up by Stephanie Moore MBE in memory of her husband, footballer Bobby Moore, after his death from the disease in 1993, at just 51
- In the 16 years since Bobby died, the Fund has gone from strength to strength and has raised over £12 million pounds through a variety of fundraising events
- Funds are spent on cutting-edge bowel cancer research carried out by leading scientists. To date we have funded 36 research fellowships and bowel cancer projects across the UK.
About Cancer Research UK
- Cancer Research UK is the world's leading charity dedicated to beating cancer through research.
- The charity's groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is funded entirely by the public.
- Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last thirty years.
- Cancer Research UK supports research into all aspects of cancer through the work of more than 4,800 scientists, doctors and nurses.
- Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7121 6699 or visit www.cancerresearchuk.org.
For media enquiries contact:
Roddy Isles
Head, Press Office
University of Dundee
Nethergate, Dundee, DD1 4HN
TEL: 01382 384910
E-MAIL: r.isles@dundee.ac.uk
MOBILE: 07800 581902 |
